IONS IONIS PHARMACEUTICALS INC Product Launches 8-K Filing 2023 - Product Launch Ionis Pharmaceuticals announced positive results for Phase 3 Balance study of olezarsen in people with familial chylomicronemia syndrome (FCS).Get access to all SEC 8-K filings of the IONIS PHARMACEUTICALS INC